Target intelligence / Profile preview

Cytosolic thiouridylase subunit 1 (CTU1)

Target
CTU1
Molecular classification
Enzyme, tRNA-modifying enzyme
01

Overview

Cytosolic thiouridylase subunit 1 (CTU1) is a conserved enzyme that, together with CTU2, forms the cytosolic tRNA 2-thiolation complex. CTU1 catalyzes the 2-thiolation at the 34th (wobble) uridine position of the anticodon loop in specific cytoplasmic tRNAs (notably tRNA^Lys^, tRNA^Glu^, and tRNA^Gln^) as part of the mcm^5^s^2^U^34^ modification. This post-transcriptional tRNA modification is critical for proper codon-anticodon recognition, translation fidelity, and global protein synthesis. Loss or deficiency of CTU1 disrupts these processes and results in genome instability, errors in translation, cell cycle arrest, impaired cell proliferation, defective angiogenesis, and abnormal nervous and erythrocyte development. Human gene mutations or dysfunction of CTU1 have been linked to multiple disease states, including congenital heart defects, developmental delay, and cancer, suggesting important roles in both normal physiology and disease. CTU1 is not currently a known drug target, and there are no drugs or biomarkers specifically associated with its modulation[1][2][3][5].

Other names
Cytoplasmic tRNA 2-thiolation protein 1ATPBD3NCS6MGC17332ATP-binding domain-containing protein 3cancer-associated gene proteincytoplasmic tRNA adenylyltransferase 1cytosolic thiouridylase subunit 1 homolog
02

Biological functions

tRNA 2-thiolationtRNA modificationcell cycle regulationcell proliferationtranslation fidelityangiogenesisembryonic development
03

Disease associations

CancerCongenital heart defectsIntellectual developmental disorderNeuropathyOther developmental disorders

Beyond the preview

Go deeper on Cytosolic thiouridylase subunit 1 (CTU1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytosolic thiouridylase subunit 1 (CTU1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call